Data Characteristics for This Category
Attenuated inactivated vaccine clinical trial data is highly specialized and structured. Data sources primarily include global clinical trial registries (e.g., ClinicalTrials.gov, WHO ICTRP) and approval documents published by regulatory agencies, as well as Clinical Study Reports (CSRs) submitted by investigators. This data updates relatively infrequently, typically quarterly or annually, coinciding with clinical trial progress or changes in approval status. Document types are diverse, including trial protocols, informed consent forms, case report forms (CRFs), statistical analysis plans (SAPs), and ethics committee approval letters. Fields and units are strictly standardized; for example, dose units are usually pfu/ml or μg, and immunogenicity indicators include neutralizing antibody titers (e.g., GMT, PRNT50) and cellular immune responses (e.g., IFN-γ ELISPOT SFC/10^6 PBMC). Additionally, trial data often contains detailed descriptions of biomarkers, adverse events (AEs), and serious adverse events (SAEs). These descriptions are frequently in free-text format and require specialized processing.
Constraints Imposed by These Characteristics on "Deployment and Upgrade"
The specialized and structured nature of attenuated inactivated vaccine clinical trial data requires the deployed system to have robust text parsing and semantic understanding capabilities to accurately extract key information. The low data update frequency means the system needs to efficiently process existing data during ingestion, with incremental updates focusing on change detection and synchronization. Diverse document types challenge the file preprocessing module, requiring support for automatic recognition and content extraction from various formats (PDF, DOCX, XML). Strict field and unit standardization necessitate that the knowledge base precisely identify and associate numerical data, supporting unit conversion and standardization. Free-text descriptions of adverse events require more advanced natural language processing models for entity recognition and event extraction to avoid information loss or misjudgment. During deployment, model training and inference resource requirements are limited by data scale. During upgrades, introducing new models or algorithms requires compatibility with old data formats and ensuring consistent results.
Configuration Settings
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
maxContext | 4000–6000 characters | Clinical trial protocols and reports are detailed; a longer context is needed to understand trial design and results. |
Chunk size (Segment Length) | 800–1200 characters | Ensures each segment contains sufficient information while preventing single segments from becoming too long and diluting semantics, especially for free-text adverse event descriptions. |
Similarity threshold (Similarity Threshold) | 0.78–0.85 | Clinical terminology and concepts require high similarity to prevent incorrect recall of information inconsistent with vaccine types or disease mechanisms. |
Recall count (Recall Count) | Top 8–12 entries | Ensures enough relevant trial details and adverse event records are recalled from a large volume of specialized documents for complex queries. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Clinical trial documents (e.g., CSRs) are large, contain charts and complex layouts, and may require longer parsing times. |
UPLOAD_FILE_MAX_SIZE | 500 MB | Accommodates the upload of original research documents containing extensive appendices and figures. |
Three Common Mistakes
- Knowledge base query results lack critical dosage or immunogenicity data because the file parser failed to correctly identify and extract numerical fields from complex tables.
- After a system upgrade, some historical conversation records are lost or fail to load because the new database schema changed, but the data migration script did not fully support the old data model.
- API calls return model responses lacking cited literature details, indicated by an empty
referencesfield in the response body. This occurs when integrating knowledge base recall with large models, failing to correctly pass or bind original segment information.
How to Confirm Correct Configuration
- Upload an attenuated inactivated vaccine clinical study report containing multi-page tables and free-text adverse event descriptions. Check if the knowledge base index is complete, particularly if key dosage, immunogenicity indicators, and detailed adverse event information are retrievable.
- Use a complex query including specific vaccine names, dosages, and target populations. Verify that the system's recall results accurately cover relevant clinical trial information and check if the
Recall count(Recall Count) meets expectations. - Query a question containing complex medical terminology via the API. Verify that the returned model answer is reasonable and cross-reference that the original segments cited in the
referencesfield are highly relevant to the answer content and traceable to the original document. - After a system upgrade, randomly select a batch of historical conversation records for querying. Confirm that conversation content, associated knowledge points, and cited literature details display normally, with no data loss.
The values provided are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.